What Laverty Pathology does

Laverty Pathology is a major provider of pathology and medical diagnostic services in New South Wales and the Australian Capital Territory, operating as a brand under Healius Pathology Pty Ltd — a wholly-owned subsidiary of Healius Ltd, an ASX top-100 listed healthcare group. The business traces its heritage to 1928, when Dr Eva Shipton established one of Australia's first specialist pathology practices in Sydney; over decades it grew by absorbing successive pathology practices (Maynard, Orban, Lindsell, Hale, Cottom, Woods, Moses, Patwardhan) and was reconstituted in 2008 through the merger of SDS Pathology with Symbion Laverty Pathology. Today Laverty runs more than 550 patient collection centres across NSW and ACT, supports more than 20,000 Australian clinicians annually via its Healius MQLink electronic data interchange (EDI) software, and operates as part of a 2,000+-centre national network through Healius.

The company's core product is medical pathology testing — blood, body fluid, tissue, cytology, infectious disease, genetic/molecular, hormone, and occupational health testing — delivered through NATA-accredited laboratories certified to ISO 15189 and ISO 17025 standards. The technology stack centres on the proprietary Medway suite (Medway Results for clinicians, Medway Practice for consumables and courier ordering, Medway Clinical Trials Portal for pharma/biotech sponsors with HL7 electronic ordering, auditing, blinding, and protocol-specific exclusion flagging) plus the Healius MQLink EDI software that injects results into clinician desktop systems using HL7/PIT data formats. The most recent capability emphasis is on AI-assisted diagnostics, in which machine learning assists pathologists in interpreting results with mandatory human oversight; no automated patient decisions are made by AI. Adjacent digital services include telehealth, eReferrals, online appointment booking, mobile collections, vaccine supply, CPD education and personalised referral pads.

Laverty's revenue model mixes Medicare bulk billing for MBS-eligible pathology tests with out-of-pocket patient payments for non-covered tests (insurance, employment, immigration, legal testing). Commercial streams — including AS/NZS 4308 and AS/NZS 4760 accredited drug and alcohol testing, employee wellness screening, biological monitoring for hazardous exposure, and clinical-trial laboratory services for pharmaceutical and biotech sponsors — generate revenue on a transaction-fee and professional-services basis. The customer base splits between long-tail patient/clinician volume (a referral-driven B2B2C model anchored to 20,000+ doctors) and dedicated enterprise clients (employers and pharma sponsors). Distribution is physical-collection-centre-led with online booking support, while enterprise commercial work is sold through direct field sales.

Name

Laverty Pathology

Legal name

Healius Pathology Pty Ltd

Website

https://laverty.com.au

Company type

Private

Founded year

1928

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Laverty Pathology provides medical pathology testing across NSW and ACT via 550+ collection centres, part of Healius Ltd's Australian network. It serves patients, 20,000+ clinicians, employers, and pharmaceutical sponsors with diagnostic, drug-testing, wellness, and clinical-trial laboratory services.

Ownership category

akta.pro rank

Product category

Diagnostic Pathology Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Scientific Research and Development Services (5417)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

akta.pro secondary industries

Anatomic Pathology LIS & Digital Pathology Workflow (HLACAMAB), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)

Keywords

• Pathology diagnostics services
• Medical laboratory testing
• Drug and alcohol screening
• Clinical trials laboratory
• Occupational health testing

Headquarters

HQ city

Port Macquarie

HQ country

Australia

HQ region

Oceania

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Medicare Pathology Services: Bulk billing for pathology tests covered under Medicare Benefits Schedule (MBS). Revenue received from Medicare Australia for eligible tests requested by healthcare providers.
2. Out-of-Pocket Patient Payments: Patient payments for tests not covered by Medicare, including insurance, employment, visa/immigration, pre-employment, or legal testing. Also for patients not eligible for Medicare or specialized tests not eligible for bulk billing.
3. Commercial Drug & Alcohol Testing: Workplace drug and alcohol testing services for employers including AS4308 urine testing, AS4760 oral fluid testing, hair drug screening, and chain of custody consumables.
4. Employee Wellness & Occupational Health: Corporate wellness screening programs including pre-employment health checks, occupational risk testing, cholesterol, glucose, liver function, thyroid and PSA testing.
5. Clinical Trial Services: Comprehensive laboratory services for pharmaceutical, biotech, and research organisations supporting clinical trials (Phases I-IV) including testing, logistics, and data management.
6. Biological Monitoring Testing: Testing services for workers exposed to hazardous chemicals including baseline monitoring, ongoing health monitoring, and employee health concerns related to chemical exposure.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Core offering

Laverty Pathology operates a network of over 550 collection centres across New South Wales and the Australian Capital Territory, providing medical pathology and diagnostic testing services including blood tests, body fluid testing, tissue pathology, cytology, infectious disease screening, and genetic/molecular testing. The company also delivers commercial services such as NATA-accredited workplace drug and alcohol testing, employee wellness screening, biological monitoring for hazardous chemical exposure, and laboratory services for pharmaceutical and biotech clinical trials. Digital clinician tools (Medway Results, Medway Practice) and Healius MQLink EDI software support electronic ordering and real-time result delivery into clinical software systems.

Product overview

Laverty Pathology is a leading pathology provider in New South Wales and Australian Capital Territory, operating as part of the Healius Pathology national network (a top 100 ASX publicly listed entity). The company traces its roots to 1928. It operates as a single integrated pathology services company offering a unified service rather than a modular platform architecture. The core offering encompasses diagnostic pathology testing services delivered through a network of over 550 collection centres, supported by digital platforms including Medway Results (real-time clinician results portal), Medway Practice (consumables and courier management), and Healius MQLink (EDI integration with clinical software systems). Commercial services include accredited drug and alcohol testing (AS/NZS 4308 and AS/NZS 4760), employee wellness screening, biological monitoring testing, and clinical trials laboratory services. The company also provides mobile collections, online appointment booking, eReferrals, telehealth, CPD education, vaccine supply, and personalised referral pads as supplementary service modules.

Differentiator

Problem solved

Functional benefit

Products and services

• Pathology Testing Services Comprehensive medical laboratory and pathology testing including blood tests, body fluid testing, tissue pathology, cytology, health screening, infectious disease testing, genetic and molecular testing, hormone testing, and occupational pathology. Bulk-billed under Medicare when requested by a healthcare provider; out-of-pocket fees apply for non-Medicare tests.
• Drug and Alcohol Testing Services NATA-accredited workplace drug and alcohol testing for employers, covering urine immunoassay screening (AS/NZS 4308), oral fluid testing (AS/NZS 4760), LCMS confirmation, hair drug screening, breath alcohol testing, chain of custody consumables, policy assistance, and expert consultation.
• Employee Wellness Screening Tailored workplace health assessment programs for employers including pre-employment health checks, occupational risk testing (COVID, heavy metals, pesticides, Q fever, hepatitis, TB), cholesterol, glucose, liver function, thyroid, and PSA testing. Available on-site or off-site.
• Biological Monitoring Testing Occupational health testing for workers exposed to hazardous chemicals including baseline monitoring, ongoing health monitoring, and assays for lead, mercury, chromium, zinc, arsenic, cadmium, herbicides, pesticides, Q fever, hepatitis, TB, and cholinesterase levels.
• Clinical Trials Laboratory Services Comprehensive laboratory services supporting clinical trials (Phases I-IV) for pharmaceutical, biotech, and research organisations. Includes dedicated project management, access to 2,000+ tests, national temperature-controlled logistics, Medway Clinical Trials Portal with HL7 electronic ordering, protocol-specific exclusion flagging, blinding solutions, and integration with Agilex Biolabs partner laboratories.
• Collection Centre Network Network of 550+ collection centres across NSW and ACT, plus 2,000+ nationally via the Healius Pathology network. Most routine tests available without appointment; specialised tests require pre-booking. Includes dedicated corporate collection centres and mobile testing vans.
• Mobile Collections Service Mobile specimen collection for patients unable to attend a collection centre due to medical, mobility, or residential care needs, including home visits and in-facility collections across metro areas with clinical-need prioritisation.
• Healius MQLink Electronic Data Interchange (EDI) Proprietary EDI software that automatically downloads Laverty pathology results into clinicians' existing desktop clinical software systems. Supports Windows and macOS and PIT or HL7 data formats. Used and trusted by over 20,000 Australian doctors annually.

Quantifiable outcome

• Routine pathology tests processed and sent to doctors within 48 hours
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability3 records

Feature5 records

Partnerships

Four partnerships are on record, tiered flagship and core.

• Healius Pathology NetworkflagshipStrategic or Co-development PartnerLaverty Pathology is part of the Healius Pathology national network, which comprises Australia's premier medical laboratories. The network includes Dorevitch Pathology (Victoria), QML Pathology (Queensland), Abbott Pathology (South Australia), Western Diagnostic Pathology (Western Australia/Northern Territory), TML Pathology (Tasmania), and other specialized pathology services.
• Agilex BiolabscoreTechnology or IntegrationSpecialized bioanalytical testing partner with FDA-inspected facilities for clinical trial support services.
• Clinical Trial SponsorscoreStrategic or Co-development PartnerPartnership with pharmaceutical, biotech, and research organisations providing Phase I-IV clinical trial laboratory services, testing logistics, and data management.
• Healthcare Software VendorscoreTechnology or IntegrationIntegration partnerships with clinical software systems enabling automatic pathology result downloads. Healius MQLink works with all major desktop clinical software systems in Australia.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Market position

Strengths4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laverty Pathology